Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SHE:000766)
China · Delayed Price · Currency is CNY 25.16
+0.25 (1.00%)
Jun 9, 2026, 3:04 PM CST
SHE:000766 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 31.83 | 34.29 | 56.44 | 43.93 | 30.15 | 35.27 |
Depreciation & Amortization | 62.24 | 62.24 | 66.94 | 74.74 | 71.62 | 69.39 |
Other Amortization | 0.68 | 0.68 | 0.44 | 0.29 | 0.18 | 0.61 |
Loss (Gain) From Sale of Assets | 0.05 | 0.05 | 0.17 | 0.21 | 0.02 | -0.83 |
Asset Writedown & Restructuring Costs | 0.28 | 0.28 | -0.12 | -0.22 | 0.11 | 0.59 |
Loss (Gain) From Sale of Investments | -5.18 | -5.18 | -2.42 | 2.61 | -1.3 | -11.13 |
Provision & Write-off of Bad Debts | -0.63 | -0.63 | 3.65 | 8.98 | -3.09 | -3.19 |
Other Operating Activities | 86.02 | 84.58 | 86.83 | 82.54 | 91.05 | 89.12 |
Change in Accounts Receivable | -7.47 | -7.47 | 2.64 | -50.56 | - | -5.87 |
Change in Inventory | 18.01 | 18.01 | -10.47 | 10.18 | 4.12 | 54.74 |
Change in Accounts Payable | -84.83 | -84.83 | -42.8 | -60.45 | 3.03 | -116.27 |
Operating Cash Flow | 104.04 | 105.05 | 162.75 | 112.78 | 198.16 | 138.33 |
Operating Cash Flow Growth | -51.77% | -35.45% | 44.31% | -43.09% | 43.25% | 71.40% |
Capital Expenditures | -61.75 | -64.07 | -49.17 | -26.67 | -23.74 | -25.48 |
Sale of Property, Plant & Equipment | 0.03 | 0.03 | 0.05 | 0.33 | 1.59 | 1.01 |
Cash Acquisitions | - | - | - | - | - | 0.03 |
Divestitures | - | - | - | - | - | 16.68 |
Investment in Securities | 0 | 0 | 0 | -0.93 | 0.91 | 0.01 |
Other Investing Activities | 26.15 | 25.18 | - | 100.4 | - | 12 |
Investing Cash Flow | -35.57 | -38.85 | -49.12 | 73.13 | -21.24 | 4.25 |
Long-Term Debt Issued | - | 1,853 | 234.5 | 130 | 1,607 | 40 |
Long-Term Debt Repaid | - | -1,840 | -135.87 | -227.45 | -1,663 | -296.9 |
Net Debt Issued (Repaid) | 178.39 | 12.64 | 98.63 | -97.45 | -55.82 | -256.9 |
Common Dividends Paid | -81.88 | -81.32 | -84.98 | -83.32 | -88.6 | -97.5 |
Other Financing Activities | -0.21 | -0.13 | -20.55 | -73.09 | - | - |
Financing Cash Flow | 96.3 | -68.8 | -6.89 | -253.86 | -144.42 | -354.4 |
Net Cash Flow | 164.78 | -2.6 | 106.73 | -67.95 | 32.5 | -211.82 |
Free Cash Flow | 42.3 | 40.99 | 113.58 | 86.11 | 174.42 | 112.85 |
Free Cash Flow Growth | -74.51% | -63.91% | 31.89% | -50.63% | 54.56% | 83.35% |
Free Cash Flow Margin | 3.61% | 3.50% | 8.59% | 5.85% | 11.86% | 7.45% |
Free Cash Flow Per Share | 0.05 | 0.05 | 0.12 | 0.10 | 0.17 | 0.13 |
Cash Income Tax Paid | 148.59 | 153.54 | 85.12 | 115.33 | 85.7 | 96.82 |
Levered Free Cash Flow | -20.25 | -38.69 | -21.21 | 28.71 | 96.14 | 112.66 |
Unlevered Free Cash Flow | 31.39 | 12.49 | 31.91 | 80.68 | 151.64 | 173.41 |
Change in Working Capital | -71.24 | -71.24 | -49.18 | -100.31 | 9.43 | -41.51 |